1921
Volume 19, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

A formalin-inactivated EEE vaccine prepared in chick-embryo cell cultures was evaluated in man. Studies with 16 volunteers given three doses of 0.5 ml subcutaneously showed only mild reactions in some persons; no meaningful changes in clinical laboratory values occurred during the evaluation period. The serologic responses of volunteers suggested that a two-dose series with a 28-day interval between doses would result in significant and persistent titers. This schedule was employed for immunization of 92 “at-risk” laboratory workers with no known experience with EEE. Twenty-eight days after the two-dose series, 93% had a log neutralization index (LNI) of ≥1.7, with all but two persons having an LNI of ≥2.0. Use of the vaccine in 117 persons who had been inoculated with EEE vaccine demonstrated the immunogenicity of the vaccine when given intradermally in a 0.1-ml dose. Of 95 persons with a titer of <1.7 at the time of the booster dose, 85 (89%) responded to a level of ≥1.7 by 28 days after the booster. This is indicative of the high immunogenicity of the vaccine given intradermally in a 0.1-ml dose.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1970.19.123
1970-01-01
2017-09-22
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1970.19.123
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error